Baseline <scp>HbA1c</scp> and dementia risk at <scp>SGLT2i</scp> initiation in type 2 diabetes
Baseline HbA1c at SGLT2i initiation predicts dementia risk. Delaying therapy until HbA1c ≥9% may forfeit protection, whereas earlier use may safeguard brain, heart and kidney health.
Authors
- Szu‐Yuan Wu (ORCID: https://orcid.org/0000-0001-5637-558X)
- Mingyang Sun (ORCID: https://orcid.org/0009-0004-8217-6508)
- Liang Zhao (ORCID: https://orcid.org/0000-0001-8197-6686)
- Fangfang Li (ORCID: https://orcid.org/0000-0003-1485-4261)
- Mengrong Miao (ORCID: https://orcid.org/0000-0002-6956-8599)
- Zhongyuan Lu (ORCID: https://orcid.org/0000-0002-0897-7006)
- Wan‐Ming Chen (ORCID: https://orcid.org/0009-0009-6628-0635)
- Yi Yang (ORCID: https://orcid.org/0000-0002-9400-1850)
- Yangyang Wang (ORCID: https://orcid.org/0000-0002-2095-5002)
- Jiao Wang (ORCID: https://orcid.org/0000-0001-6059-9279)
- Jiaqiang Zhang (ORCID: https://orcid.org/0000-0002-4329-784X)
Institutions
- Fu Jen Catholic University (TW)
- Asia University (TW)
- Luodong Poh-Ai Hospital (TW)
- Zhengzhou University (CN)
- Henan Academy of Sciences (CN)
- Ministry of Health and Welfare (TW)
- Henan Provincial People's Hospital (CN)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1111/dom.70223
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00